
Peter Jensen, MD
Chairman, Board of Directors, ARUP Presidential Endowed Chair
Professor and Chair of the Department of Pathology, University of Utah School of Medicine
Education
- Medical Degree—Vanderbilt University
- Internship—Pathology, Barnes-Jewish Hospital
- Residency—Pathology, Barnes-Jewish Hospital
Certification/Affiliations
- American Board of Pathology
- President-Elect, President, Past-President, Association of Pathology Chairs
- Chairman, Board of Directors, ARUP Laboratories
- Chair, AAI Committee on Public Affairs
- APC Exploratory Development Committee
- APC Research Committee
Research Interests
- Healthcare transformation
- Precision diagnostics
- Application of new technology in pathology and laboratory medicine
- Antigen processing and presentation
- MHC molecules in regulating immune responses
- Type 1 diabetes/autoimmunity
- Cancer immunotherapy
Awards
- Summa Cum Laude, 1977
- Elected to American Society for Clinical Investigation, 1996
- Deans Clinical Investigator Award, 2000, 2002
- NIH MERIT Award, 2001
- CAP President’s Honors Award, 2011
- Distinguished Fellow of the American Association of Immunologists, 2020
Recent Publications
- Ghosh D, et al. Regulation of the BCR signalosome by the class II peptide editor, H2-M, affects the development and repertoire of innate-like B cells. Cell Rep. 2022;38(4):110200.
- Bailey DN, et al. Generating discretionary income in an academic department of pathology. Acad Pathol. 2021;8:23742895211044811.
- Kim H, et al. Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes. J Exp Med. 2021;218(3):e20200533.
- Reyes-Vargas E, et al. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft. J Biol Chem. 2020;295(10):2959–73.
- Xiao H, et al. Elimination of osteosarcoma by necroptosis with graphene oxide-associated anti-HER2 antibodies. Int J Mol Sci. 2019;20(18):4360.
- Zhou Z, et al. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. Eur J Immunol. 2017;47:314–26.